Venture capital investment in Asia ... companies attracted capital and stole the limelight, according to KPMG. Funding across the region dropped 32 per cent to US$12.9 billion from the preceding ...

AIC chief executive Navleen Prasad said mounting pressure on the super industry to lower fees had driven funds away from more expensive venture capital and private equity vehicles despite the ...

A venture capitalist (VC) is a private equity investor who provides capital to companies with high growth potential in exchange for an equity stake. VC investments typically involve funding ...

Sun Pharmaceutical ... funding to develop a deuterated ruxolitinib treatment for hair loss. The Federal Circuit majority found that this “expression of intent,” including allocation of ...

In its first-quarter 2025 investor letter, Mairs & Power Balanced Fund highlighted stocks such as Bio-Techne Corporation (NASDAQ:TECH).Bio-Techne Corporation (NASDAQ:TECH), with a market ...

The report presents the most comprehensive, data-driven analysis of ... en/ Global Venture Debt Report 2025 By Stride Ventures and Kearney As venture capital funding becomes selective, alternative ...

Venture capital funding in the quarter ending in March hit $3 billion for the first time since the second quarter of 2022. The average asking rate for space was $73.44 per square foot, according ...

The UNICEF Venture ... capital, philanthropic investors, governments, incubators, and international organizations can help identify and match the most promising innovations for funding and mentorship.

We believe in taking the time to get to know you, your family and your objectives so we can ensure your financial plan is aligned to your aspirations.

While investors look for safe havens, investment criteria will shift towards value-based, milestone-driven capital allocation ... The days of funding future value without clear fundamentals are coming ...

Debt financing occurs when a firm raises money for working capital or capital expenditures ... can be difficult to obtain but it provides funding at lower rates than equity financing for many ...

Beijing biotech Sironax has closed a whopping $200 million second-round financing that shows investors still have a desire to back companies working on RIPK1 inhibitors despite setbacks for GSK in ...